Literature DB >> 11147900

Brain biopsy sampling by using prospective stereotaxis and a trajectory guide.

W A Hall1, H Liu, A J Martin, R E Maxwell, C L Truwit.   

Abstract

OBJECT: The authors describe their initial results obtained using a skull-mounted trajectory guide for intraoperative magnetic resonance (MR) imaging-guided brain biopsy sampling. The device was used in conjunction with a new methodology known as prospective stereotaxis for surgical trajectory alignment.
METHODS: Between January 1999 and March 2000, 38 patients underwent 40 brain biopsy procedures in which prospective stereotaxis was performed with the trajectory guide in a short-bore 1.5-tesla MR imager. In most cases, orthogonal T2-weighted half-Fourier acquisition single-shot turbo spin-echo (HASTE) images were used to determine the desired trajectory and align the device. The surgical trajectory was defined as a line connecting three points: the target, pivot, and alignment stem points. In all cases, surgical specimens were submitted for frozen section and pathological examination. Postoperative turbofluid-attenuated inversion-recovery and gradient-echo images were obtained to exclude the presence of hemorrhage. Trajectory determination and alignment was simple and efficient, requiring less than 5 minutes. Confirmatory HASTE images were obtained along the biopsy needle as it was being advanced or after reaching the target. All biopsy procedures yielded diagnostic tissue. One patient with a lesion near the motor strip experienced a transient hemiparesis of the hand related to passage of the biopsy needle, and another sustained a fatal postoperative myocardial infarction. No patient suffered a clinically significant or radiologically visible hemorrhage.
CONCLUSIONS: In combination with prospective stereotaxis, the trajectory guide provided a safe and accurate way to perform brain biopsy procedures.

Entities:  

Mesh:

Year:  2001        PMID: 11147900     DOI: 10.3171/jns.2001.94.1.0067

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  6 in total

1.  Novel platform for MRI-guided convection-enhanced delivery of therapeutics: preclinical validation in nonhuman primate brain.

Authors:  R Mark Richardson; Adrian P Kells; Alastair J Martin; Paul S Larson; Philip A Starr; Peter G Piferi; Geoffrey Bates; Lisa Tansey; Kathryn H Rosenbluth; John R Bringas; Mitchel S Berger; Krystof S Bankiewicz
Journal:  Stereotact Funct Neurosurg       Date:  2011-04-14       Impact factor: 1.875

2.  An optimized system for interventional magnetic resonance imaging-guided stereotactic surgery: preliminary evaluation of targeting accuracy.

Authors:  Paul S Larson; Philip A Starr; Geoffrey Bates; Lisa Tansey; R Mark Richardson; Alastair J Martin
Journal:  Neurosurgery       Date:  2012-03       Impact factor: 4.654

3.  Subthalamic nucleus deep brain stimulator placement using high-field interventional magnetic resonance imaging and a skull-mounted aiming device: technique and application accuracy.

Authors:  Philip A Starr; Alastair J Martin; Jill L Ostrem; Pekka Talke; Nadja Levesque; Paul S Larson
Journal:  J Neurosurg       Date:  2010-03       Impact factor: 5.115

4.  Clinical outcomes of PD patients having bilateral STN DBS using high-field interventional MR-imaging for lead placement.

Authors:  Jill L Ostrem; Nicholas B Galifianakis; Leslie C Markun; Jamie K Grace; Alastair J Martin; Philip A Starr; Paul S Larson
Journal:  Clin Neurol Neurosurg       Date:  2012-09-01       Impact factor: 1.876

5.  Role of high-field intraoperative magnetic resonance imaging on a multi-image fusion-guided stereotactic biopsy of the basal ganglia: A case report.

Authors:  Xiang Sun; Zhijuan Chen; Shuyuan Yang; Jianning Zhang; Shuyuan Yue; Zengguang Wang; Weidong Yang
Journal:  Oncol Lett       Date:  2014-11-07       Impact factor: 2.967

6.  Mobile intraoperative CT-assisted frameless stereotactic biopsies achieved single-millimeter trajectory accuracy for deep-seated brain lesions in a sample of 7 patients.

Authors:  Oliver Bichsel; Markus F Oertel; Lennart H Stieglitz
Journal:  BMC Neurol       Date:  2021-07-22       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.